ID   RL-251
AC   CVCL_S900
SY   RL251
DR   Wikidata; Q54950577
RX   PubMed=11502840;
RX   PubMed=21924324;
CC   Doubling time: 36 hours (PubMed=11502840).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
RX   PubMed=11502840; DOI=10.1210/jcem.86.8.7780;
RA   Schteingart, David E.
RA   Giordano, Thomas J.
RA   Benitez, Ricardo S.
RA   Burdick, Marie D.
RA   Starkman, Monica N.
RA   Arenberg, Douglas Allen
RA   Strieter, Robert M.
RT   "Overexpression of CXC chemokines by an adrenocortical carcinoma: a
RT   novel clinical syndrome.";
RL   J. Clin. Endocrinol. Metab. 86:3968-3974(2001).
//
RX   PubMed=21924324; DOI=10.1016/j.mce.2011.08.041; PMCID=PMC3288152;
RA   Wang, Tao
RA   Rainey, William E.
RT   "Human adrenocortical carcinoma cell lines.";
RL   Mol. Cell. Endocrinol. 351:58-65(2012).
//